Research programme: human papillomavirus therapeutics - LSBC/University of Louisville

Drug Profile

Research programme: human papillomavirus therapeutics - LSBC/University of Louisville

Latest Information Update: 26 Apr 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Large Scale Biology Corporation (CEASED); University of Louisville
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Human papillomavirus infections; Warts

Most Recent Events

  • 23 Dec 2005 Large Scale Biology Corporation ceased operations
  • 02 Aug 2004 Preclinical trials in Cancer in USA (Injection)
  • 02 Aug 2004 Preclinical trials in Human papillomavirus infections in USA (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top